Genetic Signatures Ltd
Save
143.10M
Market cap
–
Current P/E
54.95x
Forward P/E
About
Health care
Sector
Medical - Diagnostics & Research
Industry
Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens.
Similar securities
Based on sector and market capitalization
Report issue